Christopher Davis - Davis Selected Advisers
Period:    Q1 2026
Portfolio date:    31 Mar 2026
No. of stocks:    112
Portfolio value:    $21,781,443,023
Holdings Activity Buys Sells    History
Holding/activity history for  Vertex Pharmaceuticals (VRTX)
Period Shares % of Portfolio Activity % Change to Portfolio Reported Price Value Filing
2002   Q4 0 0.00 Sell 100.00% <0.01 SEC
2002   Q3 45,000 <0.01 $18.49 $832,000 SEC
2002   Q2 45,000 0.00 Reduce 0.66% $16.29 $733,000 SEC
2002   Q1 45,300 <0.01 Reduce 26.12% 1.19 $27.86 $1,262,000 SEC
2001   Q4 61,318 4.57 Reduce 0.03% <0.01 $97,298.43 $5,966,145,000 SEC
2001   Q3 61,338 2.11 Reduce 11.74% $97,259.33 $5,965,693,000 SEC
2001   Q2 69,500 0.00 Add 63.98% $85,826.69 $5,964,955,000 SEC
2001   Q1 42,384 6.31 Add 0.50% 0.03 $140,765.17 $5,966,191,000 SEC
2000   Q4 42,173 0.00 Reduce 36.10% <0.01 $141,504.14 $5,967,654,000 SEC
2000   Q3 66,000 0.01 Add 24.53% <0.01 $85.00 $5,610,000 SEC
2000   Q2 53,000 0.02 $105.34 $5,583,000 SEC
2000   Q1 53,000 <0.01 Buy <0.01 $46.81 $2,481,000 SEC